Molecular detection of GAGE expression in peripheral blood and bone marrow: Utility as a tumor marker for neuroblastoma

Clinical Cancer Research

Volumn 3, Issue 5, 1997, Pages 821-826

  Cheung, Irene Y ^a   Cheung, Nai Kong V ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; TUMOR MARKER; TYROSINE 3 MONOOXYGENASE;

ADULT; ARTICLE; BONE MARROW; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EWING SARCOMA; FOLLOW UP; GENE EXPRESSION; HUMAN; MALE; MELANOMA; MINIMAL RESIDUAL DISEASE; NEUROBLASTOMA; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR REGRESSION;

ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; HUMANS; MALE; MELANOMA; NEOPLASM STAGING; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030985833     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Osborne, M. P., and Rosen, P. P. Detection and management of bone marrow micrometastases in breast cancer. Oncology, 8: 25-42, 1994.
2. Pantel, K., Izbicki, J., Passlick, B., Angstwurm, M., Haussinger, K., Thetter, O., and Riethmuller, G. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet, 347: 649-653, 1996.
3. Moss, T. J., Reynolds, P., Sather, H. N., Romansky, S. G., Hammond, G. D., and Seeger, R. C. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N. Engl. J. Med., 324: 219-226, 1991.
4. Pantel, K., Felber, E., and Schlimok, G. Detection and characterization of residual disease in breast cancer. J. Hematotherapy, 3: 315-322, 1994.
5. Pichert, G., Roy, D-C., Gonin, R., Alyea, E. P., Bèlanger, R., Gyger, M., Perreault, C., Bonny, Y., Lerra, I., Murray, C., Soiffer, R. J., and Ritz, J. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia. J. Clin. Oncol., 13: 1704-1713, 1995.
6. Steward, C. G., Goulden, N. J., Potter, M. N., and Oakhill, A. The use of the polymerase chain reaction to detect minimal residual disease in childhood acute lymphoblastic leukemia. Eur. J. Cancer, 29A: 1192-1198, 1993.
7. Delattre, O., Zucman, J., Melot, T., Garau, X. S., Zucker, J. M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C., Triche, T. J., Aurias, A., and Thomas, G. The Ewing family of tumors: a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N. Engl. J. Med., 331: 294-299, 1994.
8. Mori, M., Mimori, K., Inoue, H., Barnard, G. F., Tsuji, K., Nanbara, S., Ueo, H., and Akiyoshi, T. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res., 55: 3417-3420, 1995.
9. Wood, D. P., Banks, E. R., Humphries, S. L., Kryscio, R. J., and Rangnekar, V. M. Comparison of immunohistochemistry and polymerase chain reaction amplification of mRNA in the detection of prostate cancer micrometastases. Proc. Am. Assoc. Cancer Res., 34: 190, 1993.
10. Miyajima, Y., Kato, K., Numata, S. I., Kudo, K., and Horibe, K. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer (Phila.), 75: 2757-2761, 1995.
11. Burchill, S. A., Bradbury, F. M., Selby, P., and Lewis, I. J. Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Eur. J. Cancer, 31A: 553-556, 1995.
12. Burchill, S. A., Bradbury, F. M., Smith, B., Lewis, I. J., and Selby, P. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int. J. Cancer, 57: 671-675, 1994.
13. Lode, H. N., Bruchelt, G., Seitz, G., Gebhardt, S., Gekeler, V., Niethammer, D., and Beck, J. Reverse transcriptase-polymerase chain reaction analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine uptake and tyrosine hydroxylase gene expression. Eur. J. Cancer, 31A: 586-590, 1995.
14. Mattano, L. A., Moss, T. J., and Emerson, S. G. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res., 52: 4701-4705, 1992.
15. van der Bruggen, P., Szikora, J., Boel, P., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw 1601. Eur. J. Immunol., 24: 2134-2140, 1994.
16. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P., Boel, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
17. Boel, P., Wildmann, C., Sensi, M., Brasseur, R., Renuald, J., Coulie, P., Boon, T., and van der Bruggen, P. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2: 167-175, 1995.
18. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 182: 689-698, 1995.
19. Matsumura, T., Ishida, H., Kadono, Y., Ohmizono, Y., Hosoi, H., Sawada, T., and Salgaller, M. L. Gene expression of the MAGE-1-encoding human melanoma antigen in pediatric tumors. Proc. Am. Assoc. Cancer Res., 35: 497, 1994.
20. Weber, J., Salgaller, M., Samid, D., Johnson, B., Herlyn, M., Lassam, N., Treisman, J., and Rosenberg, S. A. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res., 54: 1766-1771, 1994.
21. Chen, R. L., Hong, C. M., Peters, J., Matthay, K. K., and Seeger, R. C. Frequent expression of MAGE and BAGE genes by neuroblastoma. Proc. Am. Assoc. Cancer Res., 37: 463-464, 1996.
22. Brodeur, G., Pritchard, J., Berthold, F., Carlen, N. L. T., Castel, V., Castleberry, R. P., DeBernardi, B., Evans, A. E., Favrot, M., Hedborg, F., Kaneko, M., Kemshead, J., Lampert, F., Lee, R. E. J., Look, T., Pearson, A. D. J., Philip, T., Roald, B., Sawada, T., Seeger, R. C., Tsuchida, Y., and Voute, P. A. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J. Clin. Oncol., 11: 1466-1477, 1993.
23. D2 specific monoclonal antibodies. J. Clin. Oncol., 4: 363-369, 1986.
24. Kushner, B. H., O'Reilly, R. J., LaQuaglia, M., and Cheung, N. K. Dose intensive use of cyclophosphamide in ablation of neuroblastoma. Cancer (Phila.), 66: 1095-1100, 1990.
25. Kushner, B. H., LaQuaglia, M. P., Bonilla, M. A., Lindsley, K., Rosenfield, N., Yeh, S. D. J., Eddy, J., Gerald, W. L., Heller, G., and Cheung, N. K. V. Highly effective induction therapy for stage 4 neuroblastoma in children over one year of age. J. Clin. Oncol., 12: 2607-2613, 1994.
26. Naito, H., Kuzumaki, N., Uchino, J., Kobayashi, R., Shikano, T., Ishikawa, Y., and Matsumoto, S. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur. J. Cancer, 27: 762-765, 1991.
27. 2-microglobulin on human neuroblastoma cell lines. J. Immunol., 130: 2471-2478, 1983.